BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7803067)

  • 1. Use of laboratory reports to assess cervical cancer screening in a community.
    Orr ST; Celentano DD; Hill G; Erozan YS; Shediac M; Correa-Villasenor A; Matanoski G
    Am J Prev Med; 1994; 10(4):235-7. PubMed ID: 7803067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a cognition-emotion focused program to increase public participation in Papanicolaou smear screening.
    Park S; Chang S; Chung C
    Public Health Nurs; 2005; 22(4):289-98. PubMed ID: 16150010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The accuracy of Pap smear utilization self-report: a methodological consideration in cervical screening research.
    Bowman JA; Redman S; Dickinson JA; Gibberd R; Sanson-Fisher RW
    Health Serv Res; 1991 Apr; 26(1):97-107. PubMed ID: 2016170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing women's participation in Pap smear screening in Australia--how can we tell if the national policy is effective?
    Shelley J; Street A
    Aust Health Rev; 1992; 15(2):190-9. PubMed ID: 10119050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria.
    Vutuc C; Haidinger G; Waldhoer T; Ahmad F; Breitenecker G
    Wien Klin Wochenschr; 1999 May; 111(9):354-9. PubMed ID: 10407996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobilization for cervical cancer screening: lessons from a poor-urban Yoruba community in Nigeria.
    Thomas JO; Babarinsa IA; Ajayi IO; Fawole O; Ojemakinde KO; Omigbodun AO
    Afr J Med Med Sci; 2005 Mar; 34(1):81-5. PubMed ID: 15973782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pap test screening clinic in a South Asian community of Vancouver, British Columbia: challenges to maintaining utilization.
    Grewal S; Bottorff JL; Balneaves LG
    Public Health Nurs; 2004; 21(5):412-8. PubMed ID: 15363021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pap screening in a U.S. health plan.
    Insinga RP; Glass AG; Rush BB
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):355-60. PubMed ID: 15006908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pap smear screening among urban Southwestern American Indian women.
    Risendal B; DeZapien J; Fowler B; Papenfuss M; Giuliano A
    Prev Med; 1999 Dec; 29(6 Pt 1):510-8. PubMed ID: 10600432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
    Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
    J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hispanic acculturation and utilization of cervical cancer screening in the US.
    Shah M; Zhu K; Wu H; Potter J
    Prev Med; 2006 Feb; 42(2):146-9. PubMed ID: 16297444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women at risk: papanicolaou smear screening in Florida.
    Vincent AL; Greene JN; Hoercherl S; McTague D
    J Fla Med Assoc; 1997; 84(5):302-7. PubMed ID: 9260433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social and cultural barriers to Papanicolaou test screening in an urban population.
    Behbakht K; Lynch A; Teal S; Degeest K; Massad S
    Obstet Gynecol; 2004 Dec; 104(6):1355-61. PubMed ID: 15572502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community level cancer control in a Texas barrio: Part II--Base-line and preliminary outcome findings.
    McAlister AL; Fernandez-Esquer ME; Ramirez AG; Trevino F; Gallion KJ; Villarreal R; Pulley LV; Hu S; Torres I; Zhang Q
    J Natl Cancer Inst Monogr; 1995; (18):123-6. PubMed ID: 8562212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update: National Breast and Cervical Cancer Early Detection Program--July 1991-September 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jun; 45(23):484-7. PubMed ID: 8628207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
    SepĂșlveda C; Prado R
    Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
    Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
    J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
    Hewitt M; Devesa SS; Breen N
    Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.